Self-management and Quality of Life in Individuals With Type 2 Diabetes Mellitus

Sponsor
Afyonkarahisar Health Sciences University (Other)
Overall Status
Completed
CT.gov ID
NCT05983120
Collaborator
(none)
60
1
2
16.5
3.6

Study Details

Study Description

Brief Summary

The study was conducted in order to study the effect of the training given according to social-cognitive learning theory (SCLT) upon diabetes self-management and quality of life among type 2 diabetes mellitus individuals.

Condition or Disease Intervention/Treatment Phase
  • Other: Education
N/A

Detailed Description

The study was done as a randomized-controlled experimental study at Internal Diseases Polyclinics of Afyonkarahisar Public Hospital between November 2021 and August 2022. The study was completed with 60 patients -experimental group (30 patients) and control group (30 patients)- who met inclusion criteria. The data were gathered using Information Request Form and Metabolic Variables Form, Diabetes Self-Management Scale (DSMS) for Type 2 Diabetic Patients, Multidimensional Scale of Perceived Social Support (MSPSS), Type 2 Diabetes Mellitus Self-Management Questionnaire (SMQ), WHOQOL-BREF (WHO- Quality of Life Scale- Short form). A theoretical and practical training based on SCLT was provided to the experimental group for the first five weeks -one module for each week- through power point presentations and afterwards, SMS reminders were sent every fifteen days for seven weeks and at the end of the twelfth week the training was completed. The control group received a standard training from diabetes nurse. The data were assessed using statistical methods.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
The Effect of Education Provided According to Social Cognitive Learning Theory on Diabetes Self-management and Quality of Life in Individuals With Type 2 Diabetes Mellitus
Actual Study Start Date :
Aug 19, 2021
Actual Primary Completion Date :
Aug 20, 2022
Actual Study Completion Date :
Jan 3, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Training group

In the first five weeks, the experimental group was given training consisting of five modules, accompanied by power point presentations and applied social cognitive learning theory, then SMS reminders were sent every fortnight for seven weeks, and the study was completed at the end of the twelfth week. The control group received standard training from a diabetes nurse. Scale evaluations, metabolic and anthropometric measurements were made at the beginning and end of the study in the experimental and control groups. In addition, the scale evaluation was repeated in the fifth week for the experimental group. Data were evaluated using appropriate statistical methods.

Other: Education
Educate the patients who suffer from Type 2 Diabetes Mellitus

No Intervention: Control Group

The control group received standard training from a diabetes nurse.

Outcome Measures

Primary Outcome Measures

  1. Determining the principle of mutual determination from the principles of the social cognitive learning theory (SCLT) [twelve weeks]

    It was evaluated with the Multidimensional Scale of Perceived Social Support (MSPSS). The lowest score that can be obtained from the entire scale is 12, and the highest score is 84. A high score indicates high perceived social support.

  2. Determination of self-regulation capacity from the principles of SCLT. [twelve weeks]

    There is no specific score range.High scores on the scale indicate good self-management (SMQ), and low scores indicate poor self-management.

  3. Determination of self-judgment capacity, one of the principles of SCLT. [twelve weeks]

    DM was assessed with the Self-Efficacy Scale (DSMS). The lowest score that can be obtained from the scale is 20, and the highest score is 100. In the sample, the scale score average is calculated and individuals who are above the average are evaluated as high self-efficacy, and individuals below the average are evaluated as low self-efficacy.

  4. Determining the effect of SCLT-based education on Quality of Life [twelve weeks]

    Evaluated by WHOQOL - BREF (World Health Organization Quality of Life Scale - Short Form). It has four sub-dimensions: physical health such as pain, sleep, energy, psychological health such as positive emotions, self-confidence, body image, social relations such as social support, personal relations and environmental health such as economic status, transportation, safe environment and health conditions. A high score indicates a high quality of life.

Secondary Outcome Measures

  1. Determination of blood HbA1c value. [twelve weeks]

    HbA1c (glycosylated hemoglobin). Indicates the average blood glucose value over the last 2 to 3 months. The HbA1c reference range should be 5.7-6.4%. HbA1c level ≥6.5% or ≤5.6 poor glycemic control.

  2. Determination of Fasting Blood Glucose (FLA) value. [twelve weeks]

    It is the glucose value (plasma glucose) measured from a blood sample taken after eight or twelve hours of fasting. The normal reference range is min 80 mg/dl - max 130 mg/dl. FLA level ≥130 mg/dl or ≤80 mg/dl poor glycemic control.

  3. Determination of blood Postprandial Blood Glucose (TKS) value. [twelve weeks]

    TCS is the plasma glucose value measured two hours after the start of food intake after an eight-hour fast. The reference range is 140-199 mg/dl. TKS ≥200 mg/dl or ≤139 mg/dl a weak glycemic control.

  4. Determination of blood fasting lipid profile (total cholesterol, HDL-cholesterol, LDL-cholesterol, triglyceride) values. [twelve weeks]

    A blood sample taken after eight or twelve hours of fasting is used to determine the fasting lipid profile (total cholesterol, HDL-cholesterol, LDL-cholesterol, triglyceride) values. Fasting lipid profile reference range is (Total cholesterol 20 - 200 mg/dl, High Density Lipoprotein (HDL) reference range is 35 - 65 mg/dl, Low Density Lipoprotein (LDL) reference range is 60 - 130 mg/dl, Triglyceride reference range is 20 - 203 mg/dl). Values less or higher than the specified values are considered as negative cholesterol levels.

  5. Determination of Body Mass Index (BMI) [twelve weeks]

    BMI is calculated by dividing body weight (kg) by height (m) squared (kg/m²). Results below 18.5 kg/m²: Below ideal weight Results between 18.5 kg/m² and 24.9 kg/m²: At ideal weight Results from 25 kg/m² to 29.9 kg/m²: Above ideal weight Results between 30 kg/m² and 39.9 kg/m²: Well above ideal weight (obese) Results over 40 kg/m²: It is considered as well above the ideal weight (morbidly obese).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18 years and over

  • Being diagnosed with Type 2 diabetes mellitus,

  • Being on insulin therapy,

  • Being open to verbal communication,

  • Being literate

  • Not to have an obstacle to continue the implementation phase of the research (for example, pregnancy plan, changing province, etc.)

  • Not having hearing-vision problems and diabetes-related serious neuropathy (amputation, etc.),

  • Patients who agreed to participate in the study.

Exclusion Criteria:The patient has a perception disorder and psychiatric disorder that prevents communication,

  • Being pregnant,

  • Individuals with serious complications such as retinopathy and neuropathy at the level of blindness were excluded from the study.

Research Termination Criteria

  • Not performing the specified applications properly during the study,

  • Unreachable in follow-ups,

  • Those who want to quit working,

  • Serious complications related to comorbid diseases and diabetes that occur during the working process,

  • The study was terminated with patients who were moved out of the province during the study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Afyonkarahisar Health Sciences University Afyonkarahisar Turkey

Sponsors and Collaborators

  • Afyonkarahisar Health Sciences University

Investigators

  • Principal Investigator: Yasemin Celik, Afyonkarahisar Health Sciences University
  • Study Director: Sibel Karaca Sivrikaya, Balikesir University
  • Study Chair: Alper Emre Kurt, Afyonkarahisar goverment hospital
  • Study Chair: Sezen Yılmaz, Afyonkarahisar goverment hospital

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Yasemin Çelik, Dr. assistant professor, Afyonkarahisar Health Sciences University
ClinicalTrials.gov Identifier:
NCT05983120
Other Study ID Numbers:
  • Afyonkarahisar HSU
First Posted:
Aug 9, 2023
Last Update Posted:
Aug 9, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yasemin Çelik, Dr. assistant professor, Afyonkarahisar Health Sciences University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 9, 2023